taxonomy (1)
protein (48)
source (1)
structure (96)
composition (54)
disease (5)
reference (7)
site (84)
peptide (0)
- Homo sapiens (Human)
Taxonomy
- Afamin / Homo sapiens P43652
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-1b-glycoprotein / Homo sapiens P04217
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Amyloid-like protein 1 / Homo sapiens P51693
- Antithrombin-III / Homo sapiens P01008
- Apolipoprotein C-III / Homo sapiens P02656
- Apolipoprotein D / Homo sapiens P05090
- Apolipoprotein E / Homo sapiens P02649
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- C3a anaphylatoxin chemotactic receptor / Homo sapiens Q16581
- Ceruloplasmin / Homo sapiens P00450
- Chondroitin sulfate proteoglycan 5 / Homo sapiens O95196
- Clusterin / Homo sapiens P10909
- Complement c4-a / Homo sapiens P0C0L4
- Complement factor h / Homo sapiens P08603
- Complement factor i / Homo sapiens P05156
- Dickkopf-related protein 3 / Homo sapiens Q9UBP4
- Dystroglycan / Homo sapiens Q14118
- Fractalkine / Homo sapiens P78423
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- HLA class II histocompatibility antigen gamma chain / Homo sapiens P04233
- Immunoglobulin gamma-1 heavy chain / Homo sapiens P0DOX5
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Insulin-like growth factor II / Homo sapiens P01344
- Insulin-like growth factor-binding protein 6 / Homo sapiens P24592
- Kininogen-1 / Homo sapiens P01042
- Leucine-rich alpha-2-glycoprotein / Homo sapiens P02750
- Mimecan / Homo sapiens P20774
- Monocyte differentiation antigen cd14 / Homo sapiens P08571
- Neuroendocrine convertase 1 / Homo sapiens P29120
- Plasma protease c1 inhibitor / Homo sapiens P05155
- Podocalyxin-like protein 2 / Homo sapiens Q9NZ53
- Proline-rich transmembrane protein 3 / Homo sapiens Q5FWE3
- Prosaas / Homo sapiens Q9UHG2
- Prosaposin receptor gpr37l1 / Homo sapiens O60883
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Protein YIPF3 / Homo sapiens Q9GZM5
- Prothrombin / Homo sapiens P00734
- Receptor-type tyrosine-protein phosphatase-like n / Homo sapiens Q16849
- Secretogranin-3 / Homo sapiens Q8WXD2
- Serotransferrin / Homo sapiens P02787
- Sparc-like protein 1 / Homo sapiens Q14515
- Testican-1 / Homo sapiens Q08629
- Thyroxine-binding globulin / Homo sapiens P05543
Protein
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 2011
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 11737
- N-Linked / Complex / Structure 11810
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11531
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11930
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 11709
- N-Linked / Complex / Structure 11822
- N-Linked / Complex / Structure 11555
- N-Linked / Complex / Structure 11775
- N-Linked / Complex / Structure 11606
- N-Linked / Complex / Structure 11821
- N-Linked / Complex / Structure 11902
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3041
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11768
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 1586
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11466
- N-Linked / Complex / Structure 11677
- N-Linked / Complex / Structure 11867
- N-Linked / Complex / Structure 11472
- N-Linked / Complex / Structure 11784
- N-Linked / Complex / Structure 10914
- N-Linked / Complex / Structure 11578
- N-Linked / Complex / Structure 11814
- N-Linked / Complex / Structure 10835
- N-Linked / Complex / Structure 10916
- N-Linked / Complex / Structure 11750
- N-Linked / Complex / Structure 11928
- N-Linked / Complex / Structure 11498
- N-Linked / Complex / Structure 11672
- N-Linked / Complex / Structure 11674
- N-Linked / Complex / Structure 11848
- N-Linked / Complex / Structure 2369
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11563
- N-Linked / Complex / Structure 644
- N-Linked / Complex / Structure 11763
- N-Linked / Complex / Structure 11734
- N-Linked / Complex / Structure 11953
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 10184
- N-Linked / Complex / Structure 11790
- N-Linked / Complex / Structure 11916
- N-Linked / Complex / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11690
- N-Linked / Complex / Structure 11694
- N-Linked / Complex / Structure 3534
- N-Linked / Complex / Structure 11676
- N-Linked / Complex / Structure 11957
- N-Linked / Complex / Structure 11761
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Gal(b1-4)"
- N-Linked / Complex / Structure 11602
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 11646
- N-Linked / Complex / Structure 11511
- N-Linked / Complex / Structure 10918
- N-Linked / Complex / Structure 11476
- N-Linked / Complex / Structure 11550
- N-Linked / Complex / Structure 11540
- N-Linked / Complex / Structure 11635
- N-Linked / Complex / Structure 11642
- N-Linked / Complex / GlcNAc(b1-2)[GlcNAc(b1-4)]Man(a1-3)[GlcNAc(b1-2)[GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x Gal(b1-4)"
- N-Linked / Complex / Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu?c(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 10160
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 720
- N-Linked / Complex / Structure 10941
- N-Linked / Complex / Structure 11469
- N-Linked / Complex / Structure 11805
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 11726
- N-Linked / Complex / Structure 11590
- N-Linked / Complex / Structure 11922
- N-Linked / Complex / Structure 11652
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man(a1-2)"
- N-Linked / Hybrid / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
Reported structure
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 (avg mass : 1771.6509 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 NeuAc:1 (avg mass : 1973.8178 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:2 (avg mass : 1974.8459 )
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2266.1038 )
- Hex:4 HexNAc:6 (avg mass : 1885.7549 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1875.7132 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2573.3611 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:5 HexNAc:6 dHex:3 (avg mass : 2486.3263 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:7 (avg mass : 2575.3771 )
Composition
- Alzheimer's disease (DOID:10652)
- Amyotrophic lateral sclerosis (DOID:0080917)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
Disease
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins (2013 - Halim A, Rüetschi U, Larson G, Nilsson J) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- 'Brain-type' N-glycosylation of asialo-transferrin from human cerebrospinal fluid. (1995 - Hoffmann A, Nimtz M, Getzlaff R, Conradt H) / Status : Reviewed
Reference
- Afamin / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1b-glycoprotein / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Amyloid-like protein 1 / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein C-III / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Apolipoprotein E / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- C3a anaphylatoxin chemotactic receptor / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Chondroitin sulfate proteoglycan 5 / Homo sapiens
- Clusterin / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor i / Homo sapiens
- Dickkopf-related protein 3 / Homo sapiens
- Dystroglycan / Homo sapiens
- Fractalkine / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- HLA class II histocompatibility antigen gamma chain / Homo sapiens
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Insulin-like growth factor II / Homo sapiens
- Insulin-like growth factor-binding protein 6 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Mimecan / Homo sapiens
- Monocyte differentiation antigen cd14 / Homo sapiens
- Neuroendocrine convertase 1 / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Podocalyxin-like protein 2 / Homo sapiens
- Proline-rich transmembrane protein 3 / Homo sapiens
- Prosaas / Homo sapiens
- Prosaposin receptor gpr37l1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein YIPF3 / Homo sapiens
- Prothrombin / Homo sapiens
- Receptor-type tyrosine-protein phosphatase-like n / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Serotransferrin / Homo sapiens
- Sparc-like protein 1 / Homo sapiens
- Testican-1 / Homo sapiens
- Thyroxine-binding globulin / Homo sapiens
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1317.2225)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1422.3129)
-
- N-Linked / Complex
(avg mass : 1463.3655)
- Alzheimer's disease (DOID:10652)
- Amyotrophic lateral sclerosis (DOID:0080917)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1479.3649)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 1479.3649)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1479.3649)
- Afamin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Hemopexin / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Serotransferrin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1520.4175)
- Alzheimer's disease (DOID:10652)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 1520.4175)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1520.4175)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Alzheimer's disease (DOID:10652)
- Amyotrophic lateral sclerosis (DOID:0080917)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1625.5079)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Afamin / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1b-glycoprotein / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor i / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prothrombin / Homo sapiens
- Serotransferrin / Homo sapiens
- Thyroxine-binding globulin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Schizophrenia (DOID:5419)
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
- 'Brain-type' N-glycosylation of asialo-transferrin from human cerebrospinal fluid. (1995 - Hoffmann A, Nimtz M, Getzlaff R, Conradt H) / Status : Reviewed
-
Serotransferrin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1666.5605)
- Alzheimer's disease (DOID:10652)
- Amyotrophic lateral sclerosis (DOID:0080917)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
- 'Brain-type' N-glycosylation of asialo-transferrin from human cerebrospinal fluid. (1995 - Hoffmann A, Nimtz M, Getzlaff R, Conradt H) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
Serotransferrin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1666.5605)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1682.5599)
- Alzheimer's disease (DOID:10652)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 1682.5599)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1682.5599)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1723.6125)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1723.6125)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1770.6228)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1771.6509)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 1771.6509)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Alzheimer's disease (DOID:10652)
- Amyotrophic lateral sclerosis (DOID:0080917)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Afamin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Hemopexin / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Serotransferrin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1828.7029)
- Alzheimer's disease (DOID:10652)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 1828.7029)
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1828.7029)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1844.7023)
- Alzheimer's disease (DOID:10652)
- Amyotrophic lateral sclerosis (DOID:0080917)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1844.7023)
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1869.7555)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1869.7555)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1869.7555)
-
- N-Linked / Complex
(avg mass : 1869.7555)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1875.7132)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1885.7549)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1916.7658)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 1916.7658)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1916.7658)
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1932.7652)
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1932.7652)
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1973.8178)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1973.8178)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 1974.8459)
-
- N-Linked / Complex
(avg mass : 1974.8459)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Prostaglandin-h2 d-isomerase / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Alzheimer's disease (DOID:10652)
- Amyotrophic lateral sclerosis (DOID:0080917)
- Control/Healthy
- Mild Cognitive Impairment (DOID:0080832)
- Schizophrenia (DOID:5419)
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Afamin / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1b-glycoprotein / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Serotransferrin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2031.8979)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2031.8979)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2078.9082)
-
- N-Linked / Complex
(avg mass : 2079.9363)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- CSF N-glycoproteomics for early diagnosis in Alzheimer's disease (2016 - Palmigiano A, Barone R, Sturiale L, Sanfilippo C, Bua RO, Romeo DA, Messina A, Capuana ML, Maci T, Le Pira F, Zappia M, Garozzo D) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 2119.9608)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2119.9608)
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Clusterin / Homo sapiens
- Hemopexin / Homo sapiens
- Kininogen-1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2178.0409)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2194.0403)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2210.0397)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2210.0397)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2224.0231)
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment (2020 - Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, Winblad B, Dell A, Tjernberg LO) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
- N-Linked / Complex
(avg mass : 2224.0231)
-
- N-Linked / Complex
(avg mass : 2266.1038)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2282.1032)
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2282.1032)
-
- N-Linked / Complex
(avg mass : 2282.1032)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2283.1313)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2283.1313)
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2356.1827)
- Schizophrenia (DOID:5419)
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis (2019 - Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M) / Status : Reviewed
- Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia (2010 - Stanta JL, Saldova R, Struwe WB, Byrne JC, Leweke FM, Rothermund M, Rahmoune H, Levin Y, Guest PC, Bahn S, Rudd PM) / Status : Reviewed
-
Immunoglobulin gamma-1 heavy chain / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Alzheimer's disease (DOID:10652)
-
- N-Linked / Complex
(avg mass : 2370.1661)
- N-Linked / Complex
(avg mass : 2370.1661)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2356.1827)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Reported glycosite
- N-Linked / Complex
(avg mass : 2283.1313)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2283.1313)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Reported glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2282.1032)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2266.1038)
Reported glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Reported glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2210.0397)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2210.0397)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2194.0403)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2178.0409)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2119.9608)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2079.9363)
Reported glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2031.8979)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2031.8979)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Reported glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1974.8459)
Reported glycosite
- N-Linked / Complex
(avg mass : 1974.8459)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1973.8178)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1973.8178)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Reported glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Reported glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Reported glycosite
- N-Linked / Complex
(avg mass : 1916.7658)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1916.7658)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1916.7658)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1885.7549)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1875.7132)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1869.7555)
Reported glycosite
- N-Linked / Complex
(avg mass : 1869.7555)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1869.7555)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1869.7555)
Reported glycosite
- N-Linked / Complex
(avg mass : 1844.7023)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1844.7023)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1828.7029)
Reported glycosite
- N-Linked / Complex
(avg mass : 1828.7029)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1828.7029)
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1771.6509)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1771.6509)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1770.6228)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1723.6125)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1723.6125)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1682.5599)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1682.5599)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1682.5599)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1666.5605)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1666.5605)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1625.5079)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1520.4175)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1520.4175)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1520.4175)
Reported glycosite
- N-Linked / Complex
(avg mass : 1479.3649)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1479.3649)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1479.3649)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1463.3655)
Reported glycosite
- N-Linked / Complex
(avg mass : 1422.3129)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1317.2225)